S.2067: Prostate Cancer Misdiagnosis Elimination Act of 2017

About This Bill

  • This bill was introduced in the 115th Congress
  • This bill is primarily about health
  • Introduced Nov. 2, 2017
  • Latest Major Action Nov. 2, 2017

Bill Version

Bill Summary

Prostate Cancer Misdiagnosis Elimination Act of 2017 This bill provides for Medicare coverage of a DNA Specimen Provenance Assay clinical diagnostic laboratory test following a positive prostate cancer biopsy.

(Source: Library of Congress)

Bill Actions

Date Description
Nov. 2, 2017
Read twice and referred to the Committee on Finance.
Nov. 2, 2017

Introduced in the Senate by Michael D. Crapo (R-Idaho)

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page